Mechanistic role of CXCL5 in cardiovascular disease, diabetes mellitus, and kidney disease

被引:8
|
作者
Chen, Ching [1 ]
Chang, Ting-Ting [1 ,2 ]
Chen, Jaw-Wen [1 ,3 ,4 ,5 ,6 ,7 ,8 ]
机构
[1] Natl Yang Ming Chiao Tung Univ, Dept & Inst Pharmacol, Sch Med, Taipei, Taiwan
[2] Natl Yang Ming Chiao Tung Univ, Biomed Ind PhD Program, Taipei, Taiwan
[3] Taipei Med Univ Hosp, Div Cardiol, Dept Med, Taipei, Taiwan
[4] Taipei Med Univ Hosp, Dept Res, Taipei, Taiwan
[5] Taipei Med Univ Hosp, Cardiovasc Res Ctr, Taipei, Taiwan
[6] Taipei Med Univ, Taipei, Taiwan
[7] Natl Yang Ming Chiao Tung Univ, Cardiovasc Res Ctr, Taipei, Taiwan
[8] Taipei Med Univ Hosp, Dept Res, Taipei, Taiwan
关键词
Chemokine; Cardiovascular disease; Diabetes mellitus; Kidney disease; CXCL5; CHEMOKINE RECEPTORS; PEPTIDE ENA-78; NEUTROPHIL RECRUITMENT; LIGAND; 5; CELLS; EXPRESSION; CYTOKINES; OBESITY; INFLAMMATION; HOMEOSTASIS;
D O I
10.1016/j.lfs.2023.122018
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Chemokines, by modulating inflammation process, could contribute to the development of cardiovascular dis-ease, diabetes mellitus (DM), and kidney disease. Chemokine CXC motif ligand 5 (CXCL5) is one of the inducible chemokines that may be involved in various inflammatory diseases. Given the bidirectional promiscuity char-acteristics of the chemokine system, the mechanistic roles of CXCL5 should be further explored in each specific disease. In this article, we sought to review the recent evidence on the differential effects of CXCL5 and their potential mechanisms in cardiovascular disease, DM, and renal disease individually. Future study is still required to verify if CXCL5 could be a novel therapeutic target in these diseases.
引用
收藏
页数:7
相关论文
共 50 条
  • [41] Homocysteine and cardiovascular disease in diabetes mellitus
    Audelin, MC
    Genest, J
    ATHEROSCLEROSIS, 2001, 159 (02) : 497 - 511
  • [42] Diabetes mellitus and the risk for cardiovascular disease
    Joseph S. Alpert
    Current Cardiology Reports, 2003, 5 (5) : 337 - 337
  • [43] Diabetes mellitus and cardiovascular disease in women
    Sowers, JR
    ARCHIVES OF INTERNAL MEDICINE, 1998, 158 (06) : 617 - 621
  • [44] Diabetes mellitus and kidney disease in the elderly
    Iglesias, Pedro
    Heras, Manuel
    Diez, Juan J.
    NEFROLOGIA, 2014, 34 (03): : 285 - 292
  • [45] Cardiovascular disease risk in type 2 diabetes mellitus: insights from mechanistic studies
    Mazzone, Theodore
    Chait, Alan
    Plutzky, Jorge
    LANCET, 2008, 371 (9626): : 1800 - 1809
  • [46] The role of the kidney in cardiovascular disease
    Mende, Christian W.
    JOURNAL OF DIABETES, 2020, 12 (02) : 100 - 101
  • [47] Dysfunctional HDL in diabetes mellitus and its role in the pathogenesis of cardiovascular disease
    Rai Ajit K. Srivastava
    Molecular and Cellular Biochemistry, 2018, 440 : 167 - 187
  • [48] Dysfunctional HDL in diabetes mellitus and its role in the pathogenesis of cardiovascular disease
    Srivastava, Rai Ajit K.
    MOLECULAR AND CELLULAR BIOCHEMISTRY, 2018, 440 (1-2) : 167 - 187
  • [49] CXCL5 stimulation of RANK ligand expression in Paget's disease of bone
    Sundaram, Kumaran
    Rao, D. Sudhaker
    Ries, William L.
    Reddy, Sakamuri V.
    LABORATORY INVESTIGATION, 2013, 93 (04) : 472 - 479
  • [50] Risk of Cardiovascular Disease and Chronic Kidney Disease According to 2017 Blood Pressure Categories in Diabetes Mellitus
    Kim, Yong Tae
    Chung, Hyung Joon
    Park, Bo Ram
    Kim, Yeon Yong
    Lee, Jun Hyeok
    Kang, Dae Ryong
    Kim, Jang-Young
    Lee, Mi Young
    Lee, Jun Young
    HYPERTENSION, 2020, 76 (03) : 766 - 775